Request Deal Involvement
Crown Laboratories completed the acquisition of Revance Therapeutics for $924m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Centerview Partners
legal advisors
Skadden Arps Slate Meagher & Flom
pr advisors
FGS Global
legal advisors
Lowenstein Sandler
financial advisors
PJT Partners
legal advisors
Kirkland & Ellis
pr advisors
ICR
financial advisors
Leerink Partners
or
Principals
target
REVANCE THERAPEUTICS INC
bidder
CROWN LABORATORIES
bidder
HILDRED CAPITAL
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite